Literature DB >> 22268790

Nisin F-loaded brushite bone cement prevented the growth of Staphylococcus aureus in vivo.

A D van Staden1, A M Brand, L M T Dicks.   

Abstract

AIMS: To determine if nisin F-loaded self-setting brushite cement could control the growth of Staphylococcus aureus in vivo. METHODS AND
RESULTS: Brushite cement was prepared by mixing equimolar concentrations of β-tricalcium phosphate and monocalcium phosphate monohydrate. Nisin F was added at 5·0, 2·5 and 1·0% (w/w) and the cement moulded into cylinders. In vitro antibacterial activity was determined using a delayed agar diffusion assay. Release of nisin F from the cement was determined using BCA protein assays. Based on scanning electron microscopy and X-ray diffraction analysis, nisin F did not cause significant changes in cement structure or chemistry. Cement containing 5·0% (w/w) nisin F yielded the most promising in vitro results. Nisin F-loaded cement was implanted into a subcutaneous pocket on the back of mice and then infected with S. aureus Xen 36. Infection was monitored for 7 days, using an in vivo imaging system. Nisin F prevented S. aureus infection for 7 days and no viable cells were isolated from the implants.
CONCLUSIONS: Nisin F-loaded brushite cement successfully prevented in vivo growth of S. aureus. SIGNIFICANCE AND IMPACT OF THE STUDY: Nisin F incorporated into bone cement may be used to control S. aureus infection in vivo.
© 2012 The Authors. Journal of Applied Microbiology © 2012 The Society for Applied Microbiology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22268790     DOI: 10.1111/j.1365-2672.2012.05241.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  21 in total

1.  Nisin Z produced by Lactococcus lactis from bullfrog hatchery is active against Citrobacter freundii, a red-leg syndrome related pathogen.

Authors:  Gabriel Quintana; Maria V Niederle; Carlos J Minahk; Gianluca Picariello; María E F Nader-Macías; Sergio E Pasteris
Journal:  World J Microbiol Biotechnol       Date:  2017-09-27       Impact factor: 3.312

Review 2.  Bacteriocins - a viable alternative to antibiotics?

Authors:  Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Nat Rev Microbiol       Date:  2012-12-24       Impact factor: 60.633

Review 3.  Anti-infective properties of bacteriocins: an update.

Authors:  Riadh Hammami; Benoit Fernandez; Christophe Lacroix; Ismail Fliss
Journal:  Cell Mol Life Sci       Date:  2012-10-30       Impact factor: 9.261

Review 4.  Biochemical Features of Beneficial Microbes: Foundations for Therapeutic Microbiology.

Authors:  Melinda A Engevik; James Versalovic
Journal:  Microbiol Spectr       Date:  2017-10

Review 5.  Functions and emerging applications of bacteriocins.

Authors:  Michael L Chikindas; Richard Weeks; Djamel Drider; Vladimir A Chistyakov; Leon Mt Dicks
Journal:  Curr Opin Biotechnol       Date:  2017-08-05       Impact factor: 9.740

6.  Synthetic Antimicrobial Peptide Tuning Permits Membrane Disruption and Interpeptide Synergy.

Authors:  Francisco R Fields; Giorgia Manzo; Charlotte K Hind; Jeshina Janardhanan; Ilona P Foik; Phoebe Do Carmo Silva; Rashna D Balsara; Melanie Clifford; Henry M Vu; Jessica N Ross; Veronica R Kalwajtys; Alejandro J Gonzalez; Tam T Bui; Victoria A Ploplis; Francis J Castellino; Albert Siryaporn; Mayland Chang; J Mark Sutton; A James Mason; Shaun Lee
Journal:  ACS Pharmacol Transl Sci       Date:  2020-02-21

7.  The Effects of Continuous In Vivo Administration of Nisin on Staphylococcus aureus Infection and Immune Response in Mice.

Authors:  A M Brand; C Smith; L M T Dicks
Journal:  Probiotics Antimicrob Proteins       Date:  2013-12       Impact factor: 4.609

Review 8.  Using bacterial genomes and essential genes for the development of new antibiotics.

Authors:  Francisco R Fields; Shaun W Lee; Michael J McConnell
Journal:  Biochem Pharmacol       Date:  2016-12-08       Impact factor: 5.858

Review 9.  Imaging of small-animal models of infectious diseases.

Authors:  Linda A Jelicks; Michael P Lisanti; Fabiana S Machado; Louis M Weiss; Herbert B Tanowitz; Mahalia S Desruisseaux
Journal:  Am J Pathol       Date:  2012-11-28       Impact factor: 4.307

10.  Efficacy of Lantibiotic Treatment of Staphylococcus aureus-Induced Skin Infections, Monitored by In Vivo Bioluminescent Imaging.

Authors:  Anton Du Preez van Staden; Tiaan Heunis; Carine Smith; Shelly Deane; Leon M T Dicks
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.